Clinical trial

Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction

NCT00030498

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-12-01

PhasePHASE1

Study timeline

Study start (unknown)2001-12-01Date precision: month

Registry last updated2013-01-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adult Anaplastic Astrocytomaunresolved

Adult Anaplastic Ependymomaunresolved

Adult Anaplastic Oligodendrogliomaunresolved

Adult Brain Stem Gliomaunresolved

Adult Diffuse Astrocytomaunresolved

Adult Ependymoblastomaunresolved

Adult Giant Cell Glioblastomaunresolved

Adult Glioblastomaunresolved

Adult Gliosarcomaunresolved

Adult Mixed Gliomaunresolved

Adult Myxopapillary Ependymomaunresolved

Adult Oligodendrogliomaunresolved

Adult Pilocytic Astrocytomaunresolved

Adult Primary Hepatocellular Carcinomaunresolved

Adult Subependymomaunresolved

Advanced Adult Primary Liver Cancerunresolved

Advanced Malignant Mesotheliomaunresolved

Male Breast Cancerunresolved

Recurrent Adenoid Cystic Carcinoma of the Oral Cavityunresolved

Recurrent Adult Brain Tumorunresolved

Recurrent Adult Primary Liver Cancerunresolved

Recurrent Anal Cancerunresolved

Recurrent Basal Cell Carcinoma of the Lipunresolved

Recurrent Bladder Cancerunresolved

Recurrent Breast Cancerunresolved

Recurrent Cervical Cancerunresolved

Recurrent Colon Cancerunresolved

Recurrent Esophageal Cancerunresolved

Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavityunresolved

Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavityunresolved

Recurrent Lymphoepithelioma of the Nasopharynxunresolved

Recurrent Lymphoepithelioma of the Oropharynxunresolved

Recurrent Malignant Mesotheliomaunresolved

Recurrent Metastatic Squamous Neck Cancer With Occult Primaryunresolved

Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavityunresolved

Recurrent Mucoepidermoid Carcinoma of the Oral Cavityunresolved

Recurrent Non-small Cell Lung Cancerunresolved

Recurrent Ovarian Epithelial Cancerunresolved

Recurrent Pancreatic Cancerunresolved

Recurrent Prostate Cancerunresolved

Recurrent Rectal Cancerunresolved

Recurrent Salivary Gland Cancerunresolved

Recurrent Squamous Cell Carcinoma of the Hypopharynxunresolved

Recurrent Squamous Cell Carcinoma of the Larynxunresolved

Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavityunresolved

Recurrent Squamous Cell Carcinoma of the Nasopharynxunresolved

Recurrent Squamous Cell Carcinoma of the Oropharynxunresolved

Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavityunresolved

Recurrent Verrucous Carcinoma of the Larynxunresolved

Recurrent Verrucous Carcinoma of the Oral Cavityunresolved

Stage II Esophageal Cancerunresolved

Stage II Pancreatic Cancerunresolved

Stage III Esophageal Cancerunresolved

Stage III Pancreatic Cancerunresolved

Stage IIIB Non-small Cell Lung Cancerunresolved

Stage IV Adenoid Cystic Carcinoma of the Oral Cavityunresolved

Stage IV Anal Cancerunresolved

Stage IV Basal Cell Carcinoma of the Lipunresolved

Stage IV Bladder Cancerunresolved

Stage IV Breast Cancerunresolved

Stage IV Colon Cancerunresolved

Stage IV Esophageal Cancerunresolved

Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavityunresolved

Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavityunresolved

Stage IV Lymphoepithelioma of the Nasopharynxunresolved

Stage IV Lymphoepithelioma of the Oropharynxunresolved

Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavityunresolved

Stage IV Mucoepidermoid Carcinoma of the Oral Cavityunresolved

Stage IV Non-small Cell Lung Cancerunresolved

Stage IV Ovarian Epithelial Cancerunresolved

Stage IV Pancreatic Cancerunresolved

Stage IV Prostate Cancerunresolved

Stage IV Rectal Cancerunresolved

Stage IV Salivary Gland Cancerunresolved

Stage IV Squamous Cell Carcinoma of the Hypopharynxunresolved

Stage IV Squamous Cell Carcinoma of the Larynxunresolved

Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavityunresolved

Stage IV Squamous Cell Carcinoma of the Nasopharynxunresolved

Stage IV Squamous Cell Carcinoma of the Oropharynxunresolved

Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavityunresolved

Stage IV Verrucous Carcinoma of the Larynxunresolved

Stage IV Verrucous Carcinoma of the Oral Cavityunresolved

Stage IVA Cervical Cancerunresolved

Stage IVB Cervical Cancerunresolved

Unspecified Adult Solid Tumor, Protocol Specificunresolved

Untreated Metastatic Squamous Neck Cancer With Occult Primaryunresolved

Interventions

erlotinib hydrochlorideDRUG · verified · RxNorm: erlotinib hydrochloride

laboratory biomarker analysisOTHER

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

ChicagoIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00030498 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.